WBSCR9 Activators
WBSCR9 Activators are a collection of chemical compounds that enhance the functional activity of WBSCR9 through a variety of signaling pathways. Compounds like Forskolin and 8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) raise intracellular cAMP levels, leading to the activation of PKA. PKA, in turn, phosphorylates specific substrates that may interact with WBSCR9, potentially enhancing its functional activity. Similarly, Isoproterenol, a β-adrenergic agonist, indirectly amplifies cAMP levels, which could lead to the activation of PKA and subsequent phosphorylation of proteins that modulate WBSCR9activity. Ionomycin and Thapsigargin both increase intracellular calcium, which activates calcium-dependent protein kinases and potentially influences the phosphorylation state of WBSCR9 or its associated proteins, thus enhancing its activity. Phorbol 12-myristate 13-acetate (PMA) activates PKC, another kinase that can phosphorylate substrates to modulate WBSCR9's function, while Genistein inhibits tyrosine kinases, potentially reducing competition and indirectly increasing WBSCR9 activity.
Moreover, LY294002 and Wortmannin, both PI3K inhibitors, alter the PI3K/Akt signaling pathway, which could lead to the enhancement of WBSCR9 activity by affecting downstream proteins that interact with or regulate WBSCR9. Okadaic Acid, by inhibiting protein phosphatases, maintains proteins in a phosphorylated state that may favor WBSCR9 activation or stabilization of its active form. The calcium ionophore A23187 activates calcium-dependent signaling pathways, which could further enhance WBSCR9 activity. Lastly, SB431542 modulates Smad signaling by inhibiting TGF-β receptor kinases, which may indirectly lead to the activation of cellular processes involving WBSCR9. These diverse chemical activators, through their distinct actions on various signaling pathways, collectively elevate the functional activity of WBSCR9 without directly increasing its expression or activation, underlining the complex regulatory mechanisms that control this protein's role in cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene that directly activates adenylyl cyclase, thereby increasing the levels of cAMP within the cell. Elevated cAMP can enhance WBSCR9 activity by promoting cAMP-dependent protein kinase (PKA) signaling, which can phosphorylate substrates that may interact with or modify the activity of WBSCR9. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to phosphorylation events that may increase WBSCR9 functional activity by modifying its interaction with other proteins or by altering its cellular localization. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic agonist that indirectly increases intracellular cAMP levels through the activation of β-adrenergic receptors, which in turn activates adenylyl cyclase. The enhanced cAMP levels can lead to PKA activation, potentially increasing the activity of WBSCR9 through phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases may enhance WBSCR9 activity by phosphorylating it or proteins that modulate WBSCR9 function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which potentially enhances WBSCR9 activity by altering its phosphorylation state or the activity of proteins that interact with WBSCR9. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of substrates that may influence WBSCR9 activity by modifying its protein interactions or function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may increase WBSCR9 activity by reducing competitive tyrosine kinase signaling, which might affect proteins that regulate WBSCR9's function or localization within the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the Akt signaling pathway. By modulating this pathway, LY294002 might enhance WBSCR9 activity by affecting downstream proteins that interact with or regulate WBSCR9. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can modify the PI3K/Akt pathway's activity. This can potentially increase WBSCR9 activity indirectly by influencing the phosphorylation state or interaction of WBSCR9 with other cellular proteins. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to an increase in protein phosphorylation. This enhanced phosphorylation state might indirectly enhance the activity of WBSCR9 by stabilizing its active form or by affecting its interactions. | ||||||